All studies
RecruitingTherapeutic exploratory (Phase II)Interventional

A Phase 2a randomized, observer-blind, study to evaluate the immunogenicity and safety of mRNA-based multivalent seasonal influenza vaccine candidates in adults 18 years of age and older

Every year, seasonal flu causes illness across the UK. While current flu jabs work well, scientists are looking for ways to make them even better and faster to produce. This study looks at experimental flu vaccines made using mRNA technology, which teaches your body how to defend against flu viruses. Researchers are comparing these new jabs against a standard, licensed flu jab in adults aged 18 and older. The main goals are to check how safe the vaccines are and whether they help the body build strong protective antibodies. Taking part involves receiving a single injection, having blood tests to measure your immune response, and tracking any side effects over a six-month period. This research could help improve how we protect people against the flu in the future.

At a glance

Status
Recruiting
Phase
Therapeutic exploratory (Phase II)
Sponsor
GlaxoSmithKline Biologicals
Enrolment target
168
Start
13 Oct 2025

What is this study about?

Flu is a common viral infection that spreads easily every winter. For many people, it means fever, body aches, and fatigue, but for others, it can cause severe chest infections. Health services offer flu jabs each autumn, but flu viruses change frequently. Because of this, scientists are constantly searching for new ways to make vaccines that can be updated quickly and offer strong protection.

This clinical trial is testing new flu vaccines that use mRNA technology. You might already know about mRNA from recent vaccines used during the COVID-19 pandemic. Instead of using tiny pieces of killed virus, mRNA gives your immune cells a temporary set of instructions to create a harmless protein found on the flu virus. Your body then makes natural defences called antibodies, which help fight off the real flu if you catch it later.

In this Phase 2 study, doctors want to find out how safe these mRNA flu vaccines are and how well they work compared to an approved standard flu jab. By measuring antibody levels in blood samples, the study team can see how effectively the immune system responds. The findings will help scientists decide whether this type of jab could become a regular seasonal flu vaccine in future years.

Key takeaways

  • Tests new mRNA-based seasonal flu vaccines against a standard approved flu jab.
  • Open to adults aged 18 years and older who are in generally good health.
  • Involves a single jab, keeping a symptom diary, and several blood tests over about six months.
  • Helps scientists find out if mRNA jabs can protect against flu safely and effectively.
  • Participation is entirely voluntary, and you can withdraw at any time.

Who may be eligible?

This trial is open to men and women aged 18 and over. Because it is an early-stage study looking at how the immune system responds, researchers are generally looking for adults who are in good general health.

Before taking part, a study doctor will review your medical history. People with certain severe long-term medical conditions, allergies to vaccine ingredients, or conditions that weaken the immune system might not be able to join. This is done to ensure the study is safe for you and that the results are clear.

If you are interested, the trial team will talk through all the health checks and guidelines with you in detail before you make any decisions.

Could this study suit you?

Answer these quick questions to see if you may be eligible. This is a guide only — the research team makes the final call.

  1. I am aged 18 or older.
  2. I am in generally good health.
  3. I am willing to receive a study injection in my upper arm.
  4. I am happy to have a few blood tests taken over the first month.
  5. I am able to attend clinic visits and keep in touch with the team for six months.
Answer every question to see your result.

What does participation involve?

Taking part in this study lasts around six months. At your first visit, the team will check your overall health and take a blood sample before giving you a single injection in your upper arm. Because this is an observer-blind study, you will not know whether you receive a new mRNA vaccine or the standard flu jab.

Over the first week, you will track any local reactions, such as arm soreness, or mild symptoms like a headache or mild fever. You will also have follow-up visits with blood tests on Day 3, Day 8, and Day 29 to measure your body's immune response and check routine blood counts. After the first month, the study team will keep in touch periodically up to six months after your jab to monitor your general wellbeing and record any unusual health events.

Potential risks and benefits

You might not get any direct medical benefit from joining, although the jab could provide protection against seasonal flu. The study also helps researchers develop better vaccines for the future. As with any vaccine, there is a risk of side effects. Common ones include soreness, redness, or swelling where you had the injection, as well as mild tiredness, muscle aches, or a low fever that usually clear within a few days. Serious allergic reactions are rare, and medical staff are on hand to support you. Taking part is completely voluntary, and you are free to leave the trial at any time without your regular NHS care being affected.

Locations (1)

Some site locations are approximate. We're improving this — please verify with the trial team before travelling.
  • —
    Unverified
    Belgium

Common questions

Can I catch the flu from the study vaccine?

No. None of the vaccines in this study contain live flu viruses, so it is impossible to catch the flu from them.

What is an mRNA vaccine?

An mRNA vaccine carries a short set of natural instructions that teach your body to make antibodies. It does not alter your DNA and disappears from your body quickly after doing its job.

Will I have to pay to take part?

No. The study vaccines, tests, and medical checks are provided free of charge, and studies often offer help with reasonable travel expenses.

Will I know which vaccine I am given?

No. To keep the trial results fair and unbiased, participants do not know whether they received the experimental mRNA vaccine or the standard flu jab.

Can I leave the study if I change my mind?

Yes. You have the right to withdraw from the trial at any point, and doing so will not affect your standard NHS healthcare.

How to find out more

Always speak to your GP or specialist before deciding to take part in a study.

Interested in taking part?

Register your interest

Share your details and the research team for "A Phase 2a randomized, observer-blind, study to evaluate the…" will contact you if you may be eligible. Always speak to your GP before agreeing to take part.

Discussion

Community discussion

Powered by our forum at community.patient.info. Please be respectful — this is not medical advice.